Precigen (PGEN) Construction in Progress (2012 - 2026)
Precigen (PGEN) reported Construction in Progress of $281000.0 for Q1 2026, down 97.23% year-over-year from $10.1 million in Q1 2025, and up 1.08% quarter-over-quarter from $278000.0 in Q4 2025.
Precigen (PGEN) Construction in Progress (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Construction in Progress data on file, last reported at $281000.0 in Q1 2026.
- Construction in Progress for Q1 2026 came in at $281000.0, down 97.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $281000.0 (down 97.23% YoY), and the FY2025 annual result was $278000.0, down 96.92% from the prior year.
- Construction in Progress advanced to $281000.0 in Q1 2026 per PGEN's latest filing, from $278000.0 in the prior quarter.
- Over five years, Construction in Progress peaked at $10.4 million in Q2 2025 and troughed at $106000.0 in Q2 2023.
- A 5-year average of $3.7 million and a median of $1.2 million in 2022 frame the typical range for Construction in Progress.
- The sharpest annual moves came in 2024 and 2026: Construction in Progress surged 7550.0% in 2024, then plunged 97.23% in 2026.
- A 5-year view of Construction in Progress shows it stood at $531000.0 in 2022, then soared by 196.99% to $1.6 million in 2023, then surged by 471.91% to $9.0 million in 2024, then sank by 96.92% to $278000.0 in 2025, then grew by 1.08% to $281000.0 in 2026.
- Business Quant data shows PGEN's Construction in Progress at $281000.0 in Q1 2026, $278000.0 in Q4 2025, and $263000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | 281,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 281,000.00 |
| Dec 31, 2025 | 278,000.00 |
| Sep 30, 2025 | 263,000.00 |
| Jun 30, 2025 | 10.44 Mn |
| Mar 31, 2025 | 10.13 Mn |
| Dec 31, 2024 | 9.02 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 8.11 Mn |
| Mar 31, 2024 | 7.31 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Sep 30, 2023 | 892,000.00 |
| Jun 30, 2023 | 106,000.00 |
| Mar 31, 2023 | 151,000.00 |
| Dec 31, 2022 | 531,000.00 |
| Sep 30, 2022 | 1.24 Mn |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 3.60 Mn |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 2.73 Mn |
| Jun 30, 2021 | 2.19 Mn |